Michael Thomas Serzan
- Medicare services, 2024
- 540
- Medicare patients, 2024
- 235
- Part D claims, 2024
- 363
- MIPS score, 2024
- 84
- Hospital affiliations
- 5
- Practice address
- 450 Brookline Avenue, Boston, MA 02115
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Michael Serzan's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Michael Thomas Serzan is a medical oncologist in Boston, Massachusetts
Michael Serzan practices at Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute.
Michael Serzan's NPI, 1407241532, was assigned on April 6, 2015. Michael Serzan graduated from Rutgers New Jersey Medical School in 2015. Michael Serzan holds Massachusetts license 291977.
- NPI
- 1407241532NPI Registry (opens in a new tab)
- Medicare PAC ID
- 3678955937
- NPI enumeration date
- April 6, 2015
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 37
- Medical school graduation
- 2015
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Michael Thomas Serzan practices at Dana-Farber Cancer Institute in Boston, Massachusetts
Michael Serzan's primary practice is Dana-Farber Cancer Institute, at 450 Brookline Avenue, Boston, MA 02115.
- Dana-Farber Cancer Institute450 Brookline Avenue, Boston, MA 02115
Source: Dmand AI Affiliation Data
Michael Thomas Serzan is affiliated with 6 sites of care and 1 medical group
Michael Serzan's primary practice is Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute. Michael Serzan is also affiliated with Massachusetts General Hospital. The medical group on file is Binney Medical Group. Dmand AI also links Michael Serzan to 3 more hospitals and 1 home health agency, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Michael Thomas Serzan's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Michael Serzan practices, 6 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dana-Farber Cancer Institute | Available with a free account |
| +5 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Dana-Farber Cancer Institute and 6.2K+ hospitals, with verified contacts in the same login.
Michael Thomas Serzan is one of 290 medical oncologists in Massachusetts
Medical oncology is Michael Serzan's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Michael Serzan is licensed in Massachusetts.
Specialties and state licenses
- Medical oncology, MassachusettsPrimary
Medical oncologists near Michael Serzan
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Michael Thomas Serzan billed Medicare for 540 services in 2024
CMS data shows 540 Medicare services from Michael Serzan across 4 procedure codes in 2024, for 235 Medicare patients. Medicare paid $53,660 for them.
Michael Serzan's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 4492024: 54020%
Where Michael Serzan's Medicare services took place, 2024
- In an office28753%
- In a facility25347%
Michael Serzan compared with the Massachusetts median for medical oncologists, 2024
- Michael Serzan
- Massachusetts median
- Medicare services
- 540vs 2602.1 times
- Medicare patients
- 235vs 1092.2 times
- Part D claims
- 263vs 634.2 times
Medians across 259 medical oncologists in Massachusetts with Dmand AI profiles that report each measure.
Michael Serzan's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Michael Serzan?
Medicare shows one payer. Book a meeting to get commercial claims data for Michael Serzan and other medical oncologists in Massachusetts.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Michael Thomas Serzan treated 235 Medicare patients in 2024, average age 74
CMS counts 235 Medicare patients who saw Michael Serzan in 2024. The largest group is 65 to 74, with 128 patients. 75% of them have cancer, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Michael Serzan's median patient age at 70, with 8% women.
Michael Serzan's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Michael Serzan's Medicare patients by sex, 2024
- Women219%
- Men21491%
Chronic conditions among Michael Serzan's Medicare patients, 2024
- Cancer75%
- High cholesterol75%
- High blood pressure70%
- Arthritis35%
- Ischemic heart disease25%
- Anxiety24%
- Diabetes24%
- Chronic kidney disease22%
Share of Medicare patients with each condition. A patient can have several.
Michael Serzan's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women8%
- Men91%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Michael Thomas Serzan wrote 363 Medicare Part D claims in 2024
In 2024, Michael Serzan wrote 363 Medicare Part D claims for 68 patients. 61% of them were for generic drugs. CMS names the drug for 263 of them, across 9 drugs with 11 or more claims each, at $1,359,832 in total drug cost. In 2023, CMS named 88 claims across 5 drugs.
Michael Serzan's Part D claims by kind of drug, 2024
- Generic221 claims61%
- Brand-name142 claims39%
Michael Serzan's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 882024: 263199%
Drugs named by CMS: 9 in 2024, 5 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Michael Thomas Serzan scored 84 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Michael Serzan for performance year 2024, reported as part of a group. Michael Serzan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Michael Serzan as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Michael Serzan's MIPS scores, performance year 2024
- 84of 100Final score
- 65of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 69of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Michael Thomas Serzan received $5,430 in industry payments from 2021 to 2025
CMS Open Payments shows 13 general payments to Michael Serzan from 5 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 85% of the total. AstraZeneca Pharmaceuticals LP paid the most, $3,116.
General payments to Michael Serzan by program year, 2021 to 2025
General payments to Michael Serzan by kind, 2021 to 2025
- Consulting fees$4,63885%
- Food and beverage$2615%
- Compensation for serving as faculty or as a speaker for a medical education program$2234%
- Education$2164%
- Travel and lodging$932%
Companies that paid Michael Serzan the most, 2021 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Michael Thomas Serzan graduated from Rutgers New Jersey Medical School
Michael Serzan graduated from Rutgers New Jersey Medical School in 2015.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Michael Thomas Serzan's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Michael Thomas Serzan
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Michael Thomas Serzan's NPI number?
Michael Thomas Serzan's NPI number is 1407241532. It was assigned on April 6, 2015, and it is active in the NPI Registry.
What does Michael Thomas Serzan specialize in?
Michael Thomas Serzan is a medical oncologist in Boston, Massachusetts. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Michael Thomas Serzan practice?
Michael Serzan practices at 450 Brookline Avenue, Boston, MA 02115. Michael Serzan's primary practice is Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute. Dmand AI also links Michael Serzan to 3 hospitals and 1 home health agency.
What is Michael Thomas Serzan's medical license number?
Michael Serzan holds Massachusetts license 291977.
Which hospitals is Michael Thomas Serzan affiliated with?
Michael Serzan practices at Dana-Farber Cancer Institute in Boston, Massachusetts. Michael Serzan is also affiliated with Massachusetts General Hospital. Dmand AI links Michael Serzan to 3 more hospitals.
What medical group is Michael Thomas Serzan part of?
Michael Serzan is linked to Binney Medical Group.
Does Michael Thomas Serzan accept Medicare?
Yes. CMS data shows Michael Serzan billed Medicare for 540 services in 2024, and Michael Serzan accepts Medicare assignment.
Does Michael Thomas Serzan offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Michael Serzan as offering telehealth services.
What is Michael Thomas Serzan's MIPS score?
Michael Serzan's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.
How many Medicare patients does Michael Thomas Serzan see?
CMS counts 235 Medicare patients who saw Michael Serzan in 2024, with an average age of 74.
Show 5 more questionsShow fewer questions
What services does Michael Thomas Serzan bill to Medicare?
In 2024, Michael Serzan's most billed Medicare services were office visit, established patient (99214), office visit, new patient (99205) and office visit, established patient (99215).
Where did Michael Thomas Serzan go to medical school?
Michael Serzan graduated from Rutgers New Jersey Medical School in 2015.
What drugs does Michael Thomas Serzan prescribe most?
In 2024 Medicare Part D data, Michael Serzan's most prescribed drugs by claims were Prednisone, Nubeqa and Abiraterone Acetate.
Has Michael Thomas Serzan received payments from drug or device companies?
CMS Open Payments shows $5,430 in general payments to Michael Serzan from 5 companies from 2021 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Michael Thomas Serzan been practicing?
Michael Serzan graduated from medical school in 2015, 11 years ago.
Selling to medical oncology practices?
See medical oncologists in Massachusetts by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card